198 related articles for article (PubMed ID: 35204261)
1. Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort).
Barré T; Fontaine H; Pol S; Ramier C; Di Beo V; Protopopescu C; Marcellin F; Bureau M; Bourlière M; Dorival C; Petrov-Sanchez V; Asselah T; Delarocque-Astagneau E; Larrey D; Duclos-Vallée JC; Carrat F; Carrieri P; On Behalf Of The Anrs/Afef Hepather Study Group
Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204261
[TBL] [Abstract][Full Text] [Related]
2. Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort).
Barré T; Fontaine H; Ramier C; Di Beo V; Pol S; Carrieri P; Marcellin F; Cagnot C; Dorival C; Zucman-Rossi J; Zoulim F; Carrat F; Protopopescu C
Clin Nutr; 2022 Mar; 41(3):610-619. PubMed ID: 35124468
[TBL] [Abstract][Full Text] [Related]
3. Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort).
Barré T; Bourlière M; Ramier C; Carrat F; Di Beo V; Protopopescu C; Marcellin F; Bureau M; Cagnot C; Dorival C; Zoulim F; Zucman-Rossi J; Duclos-Vallée JC; Fontaine H; Carrieri P; The Anrs/Afef Hepather Study Group
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294456
[TBL] [Abstract][Full Text] [Related]
4. Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort).
Barré T; Pol S; Ramier C; Di Beo V; Carrat F; Bureau M; Bourlière M; Dorival C; Serfaty L; Asselah T; Boursier J; Marcellin F; Carrieri P; Fontaine H; Protopopescu C;
Cannabis Cannabinoid Res; 2022 Oct; 7(5):677-689. PubMed ID: 34648718
[No Abstract] [Full Text] [Related]
5. Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort).
Barré T; Nishimwe ML; Protopopescu C; Marcellin F; Carrat F; Dorival C; Delarocque-Astagneau E; Larrey D; Bourlière M; Petrov-Sanchez V; Simony M; Pol S; Fontaine H; Carrieri P;
J Viral Hepat; 2020 Dec; 27(12):1473-1483. PubMed ID: 32810343
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort.
Barré T; Carrat F; Ramier C; Fontaine H; Di Beo V; Bureau M; Dorival C; Larrey D; Delarocque-Astagneau E; Mathurin P; Marcellin F; Petrov-Sanchez V; Cagnot C; Carrieri P; Pol S; Protopopescu C;
J Cannabis Res; 2022 Jun; 4(1):31. PubMed ID: 35690798
[TBL] [Abstract][Full Text] [Related]
7. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
8. Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors.
Carrieri P; Carrat F; Di Beo V; Bourlière M; Barré T; De Ledinghen V; Pageaux GP; Bureau M; Cagnot C; Dorival C; Delarocque-Astagneau E; Marcellin F; Pol S; Fontaine H; Protopopescu C;
JHEP Rep; 2022 Jun; 4(6):100481. PubMed ID: 35514789
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients.
Carrieri MP; Protopopescu C; Marcellin F; Rosellini S; Wittkop L; Esterle L; Zucman D; Raffi F; Rosenthal E; Poizot-Martin I; Salmon-Ceron D; Dabis F; Spire B;
J Hepatol; 2017 Dec; 67(6):1157-1167. PubMed ID: 28942916
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Lam L; Fontaine H; Bourliere M; Lusivika-Nzinga C; Dorival C; Thabut D; Zoulim F; Habersetzer F; Asselah T; Duclos-Vallee JC; Bronowicki JP; Mathurin P; Decaens T; Ganne N; Guyader D; Leroy V; Rosa I; De Ledinghen V; Cales P; Causse X; Larrey D; Chazouilleres O; Gelu-Simeon M; Loustaud-Ratti V; Metivier S; Alric L; Riachi G; Gournay J; Minello A; Tran A; Geist C; Abergel A; Raffi F; D'Alteroche L; Portal I; Lapidus N; Pol S; Carrat F;
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101713. PubMed ID: 33930591
[TBL] [Abstract][Full Text] [Related]
11. Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B.
Hodge A; Lim S; Goh E; Wong O; Marsh P; Knight V; Sievert W; de Courten B
Nutrients; 2017 Jan; 9(1):. PubMed ID: 28075394
[TBL] [Abstract][Full Text] [Related]
12. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status.
Inoue M; Kurahashi N; Iwasaki M; Shimazu T; Tanaka Y; Mizokami M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1746-53. PubMed ID: 19505908
[TBL] [Abstract][Full Text] [Related]
13. The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area.
Jang ES; Jeong SH; Lee SH; Hwang SH; Ahn SY; Lee J; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Kim HY
Liver Int; 2013 Aug; 33(7):1092-9. PubMed ID: 23651110
[TBL] [Abstract][Full Text] [Related]
14. Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study.
Chook JB; Ngeow YF; Tee KK; Lee JWT; Mohamed R
Viruses; 2019 Sep; 11(9):. PubMed ID: 31480588
[TBL] [Abstract][Full Text] [Related]
15. Association of coffee consumption and liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B: A 5-year population-based cohort study.
Chen CL; Chang WC; Yi CH; Hung JS; Liu TT; Lei WY; Hsu CS
J Formos Med Assoc; 2019 Feb; 118(2):628-635. PubMed ID: 30122312
[TBL] [Abstract][Full Text] [Related]
16. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan.
Takami H; Nakamoto M; Uemura H; Katsuura S; Yamaguchi M; Hiyoshi M; Sawachika F; Juta T; Arisawa K
J Epidemiol; 2013; 23(1):12-20. PubMed ID: 23047663
[TBL] [Abstract][Full Text] [Related]
17. Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study.
Alferink LJM; Fittipaldi J; Kiefte-de Jong JC; Taimr P; Hansen BE; Metselaar HJ; Schoufour JD; Ikram MA; Janssen HLA; Franco OH; Darwish Murad S
J Hepatol; 2017 Aug; 67(2):339-348. PubMed ID: 28578837
[TBL] [Abstract][Full Text] [Related]
18. Social vulnerability of patients co-infected with hepatitis B and hepatitis delta viruses: Data from the ANRS CO22 HEPATHER cohort.
Marcellin F; Carrat F; Ramier C; Dorival C; Lotto M; Protopopescu C; Pol S; Fontaine H; Carrieri P;
J Clin Virol; 2021 Nov; 144():104987. PubMed ID: 34598884
[No Abstract] [Full Text] [Related]
19. Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes.
Stutz B; Ahola AJ; Harjutsalo V; Forsblom C; Groop PH;
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):470-476. PubMed ID: 29501444
[TBL] [Abstract][Full Text] [Related]
20. Association of coffee, green tea, and caffeine with the risk of dementia in older Japanese people.
Matsushita N; Nakanishi Y; Watanabe Y; Kitamura K; Kabasawa K; Takahashi A; Saito T; Kobayashi R; Takachi R; Oshiki R; Tsugane S; Iki M; Sasaki A; Yamazaki O; Watanabe K; Nakamura K
J Am Geriatr Soc; 2021 Dec; 69(12):3529-3544. PubMed ID: 34624929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
